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Background:Urogenital schistosomiasis (UGS) causes inﬂammation and ﬁbrosis of the urinary tract. In resource-
limited settings, affordable tools for morbidity assessment in clinical care are needed. Point-of-care ultrasound
has not yet been validated for UGS-related pathology.
Methods: We developed a protocol for Focused Assessment with Sonography for Urinary Schistosomiasis
(FASUS), assessing pathology of the bladder wall, ureters and kidneys. Following standardized training, two
clinicians performed FASUS on children and adults with hematuria in Lambaréné, Gabon. Recorded ultrasound
clips were remotely reviewed by two ultrasound experts as a diagnostic reference.
Results: In 2015 and 2016, scans were performed in 118 patients. The image quality was sufﬁcient in 90% of
bladder views and more than 97% of kidney views. UGS-compatible pathology was detected in 51/118 (43%)
by the operator and in 46/107 (43%) by the experts among baseline scans of sufﬁcient quality. Inter-rater
agreement between operators and experts was very good (κ > 0.8) for hydronephrosis and good (κ > 0.6) for
bladder wall thickening.
Conclusions: FASUS is a promising clinical, point-of-care tool for detecting UGS-related urinary tract morbidity
in symptomatic patients. Based on larger validation studies, appropriate diagnostic and therapeutic algorithms
for the use of FASUS should be established.
J. Remppis et al.
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Introduction
Urogenital schistosomiasis (UGS), a waterborne disabling para-
sitic neglected tropical disease, affects an estimated 112 million
people, with more than 400 million people at risk.1,2 Chronic
infection and its sequelae cause substantial morbidity reported
mainly, but not exclusively, in school-aged children and young
adults.3,4 UGS-related pathology may include bladder wall thick-
ening and/or distal ureteric wall thickening. At an advanced stage
it may include upper urinary tract obstruction and renal failure,5
as well as squamous cell carcinoma of the bladder.6 If treated
early in the course of disease, a certain proportion of the patho-
logical changes in the urinary tract are reversible.3 In patients
with irreversible damage, options for treatment will depend on
the type of damage and available treatment.
In most high- and moderate-prevalence areas the only avail-
able diagnostic tools are detection of hematuria by urine dipstick
and direct parasitological examination of the urine. These tools,
as well as novelmethods such as detection of speciﬁc antibodies,
antigens or genetic material,7–9 can conﬁrm infection but detect
neither anatomical changes due to the infection nor sequelae
after treatment.
In prevalence surveys, ultrasound has long been established
as an effective imaging tool to assess urinary tract morbidity in
UGS and tomonitor treatment response,10 with results which are
comparable with more invasive methods such as cystoscopy.11
As ultrasound is a test for morbidity from UGS, and not for active
infection, it complements, rather than replaces, parasitological
tests.
In 1996, the WHO published a standardized protocol for the
ultrasonographic assessment of schistosomiasis-relatedmorbid-
ity, commonly known as the Niamey protocol.12 However, this
protocol is speciﬁcally designed for application in large-scale
control programs and not for diagnosis in the clinical setting. It
includes a detailed and relatively complex grading system, which
is less relevant to clinical application.10 Contrary to widespread
experience of using ultrasound in prevalence surveys, it has not
been validated for routine patient care in endemic areas. In addi-
tion, prevalence surveys mostly rely on operators with profes-
sional ultrasound training. Inmany clinical settings, this expertise
is lacking.
Point-of-care ultrasound (POCUS) has been successfully imple-
mented for various other indications in tropical medicine, e.g.
HIV-associated TB and echinococcosis.13
The aim of this study was to pilot a POCUS protocol for
detection of UGS-related urinary tract morbidity in symptomatic
patients, to evaluate practical feasibility and evaluate the
performance of operators with limited training, using low-cost
equipment.
Methods
This study was conducted at the Centre de Recherches Médicales
de Lambaréné (CERMEL) located in the semi-rural setting of
Lambaréné, Gabon,whereUGS is highly prevalent.14–19 Itwas part
of a larger study, which additionally assessed epidemiological
aspects as well as immunological and metabolomic aspects of
UGS; thesewill be reported separately. Procedures relevant for the
pilot assessment of the POCUS protocol were: (1) development
of a POCUS scan protocol; (2) the training of two operators; (3)
evaluation of the diagnostic accuracy of POCUS operators, using
remote expert image review as a reference; and (4) comparing
the ultrasound ﬁndings with parasitology test results.
Protocol development
A simple and easy-to-learn protocol was designed by the study
team, selecting clinically relevant criteria from the Niamey proto-
col. The Niamey protocol provides standards for the evaluation of
the urinary bladder (shape, bladder wall thickening, irregularities
and polyps), ureters (ureteral dilation), renal pelvis (degree of
hydronephrosis), along with several additional evaluations (blad-
der volume, residual urine after voiding and ﬁbrosis of the renal
pelvis). Final evaluation includes multiple measurements for the
calculation of a ﬁnal severity score.12 Based on the nomencla-
ture of previous POCUS techniques13 we named our protocol:
‘Focused Assessment with Sonography for Urinary Schistosomia-
sis’ (FASUS). The emphasis in our scan protocol was on views that
are easily achievable and abnormalities that are easily recog-
nisable for operators with no, or very little, previous ultrasound
experience; for example, bladder wall thickening and renal pelvis
dilation. More sophisticated procedures such as measurement
of bladder volume were omitted. More sophisticated procedures
such as measurement of bladder volume were omitted, as well
as complex severity grading scores. The initial protocol comprised
a transverse scan of the bladder and an oblique and transverse
scan of both kidneys. During the course of the study a longitudinal
bladder scan was added, given the potential added value in
the detection of bladder dome pathology. Bladder abnormalities
compatible with UGSwere deﬁned as any bladder wall thickening
≥5 mm, as in the Niamey criteria, or bladder wall calciﬁcation,
regardless of kidney and ureter ﬁndings. Abnormalities of the kid-
neys and ureters without bladder pathology were not considered
compatible with UGS, as this is a highly uncommon ﬁnding and
etiologies other than UGS are more likely. A description of the
FASUS probe positions is presented in Figure 1. The scan planes
and documented variables are presented in Table 1. Examples of
target pathologies are presented in Figure 2.
Training
Two operators, a clinician (JR) and a medical student (AV), with
little and no previous ultrasound experience, respectively, were
trained on-site. POCUS training took 20 h overall. A theoretical
part included lectures on relevant literature20 and demonstration
of the FASUS protocol. The practical part consisted of ﬁve test
scans by each operator in healthy volunteers. Still images and
video clips recorded during the ﬁve test scanswere independently
and remotely reviewed by two experts, a pediatric infectious
diseases clinician with 4 y (SB) and a clinical radiologist with over
20 y of ultrasound experience (EJ). Detailed feedback on image
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Figure 1. Focused Assessment with Sonography for Urinary Schistoso-
miasis (FASUS) probe positions: 1 and 2 = transverse and longitudinal
suprapubic pelvis scan; 3 and 4 = oblique and transverse right kidney scan;
5 and 6 = oblique and transverse left kidney scan.
quality and visualization of target structures was provided, along
with practical advice for improvement of technique.
Prospective evaluation of the protocol
Participants of all ages were recruited by convenience sampling
in areas of Lambaréné that were identiﬁed as hotspots for UGS in
previous studies.16,17 Inclusion criteria were previous or ongoing
macro-hematuria; exclusion criterion were known diseases of
the urinary tract related to causes other than UGS. Convenience
sampling was considered appropriate, as this was not intended
as a prevalence survey, but as a cohort of patients with clinical
symptoms. After an initial clinical assessment, FASUS and urine
collection for parasitology were performed. Following praziquan-
tel treatment, active follow-up visits were attempted after 1 and
3 mo.
Clinical and laboratory procedures
Clinical assessment consisted of a questionnaire on present or
previous symptoms of UGS, knownbladder or kidney disease, pre-
vious praziquantel treatment, the duration of freshwater contact
and pregnancy. Three urine samples, provided between 10:00 h
and 14:00 h on three consecutive days, were requested. Semi-
quantitative urine dipstick testing as well as urine ﬁltration (10ml
Table 1. Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS) protocol
Scan planes Assessed anatomy Pathology variablesa
Suprapubic pelvis
1) Transverse Bladder wall
Distal ureters
a) Bladder wall irregularities <5 mm
thickness
b) Wall thickening 5–10 mm
c) Maximum thickening, masses or
pseudopolyps ≥10 mm
2) Longitudinalb Bladder wall
Distal ureters
d) Bladder wall calciﬁcation
e) Distal ureter dilation or thickening
f) Findings not related to urogenital
schistosomiasis
Kidneys (right and left)
3) and 5) Oblique Proximal ureter and collecting system g) Proximal ureter dilation
h) Findings not related to urogenital
schistosomiasis
4) and 6) Transverse Renal pelvis i) Renal pelvis dilation (>1 cm)
• If abnormal, conﬁrmed after
bladder voiding
j) Findings not related to urogenital
schistosomiasis
aany of b), c) or d) was deﬁned as a pathology compatible with urogenital schistosomiasis.
badded to the protocol after recruitment of 45 cases because a higher sensitivity in the detection of bladder wall thickening was assumed.
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Figure 2. Examples of target pathologies detected by Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS).
urine) for microscopy for the presence of Schistosoma haema-
tobium were performed (Dipstick: Combur 10 Test, Roche Diag-
nostics Ltd, Risch, Switzerland; Millipore ﬁlter: Nuclepore Track-
Etch Membrane Filtration Products, Whatman, Maidstone, UK;
microscope: Eclipse E200MV R, Nikon, Tokyo, Japan). A positive
result was deﬁned as any detection of eggs in the ﬁltered urine.
Heavy intensity infection was deﬁned as≥50 eggs/10 ml urine.21
In addition, 10 ml of urine was centrifuged for 5 min at 710 x g
and, after discarding the supernatant, 500 μl of urine was stored
at −20◦C for Schistosoma genus PCR. In the case of negative
microscopy, urine real-time PCR for Schistosoma-speciﬁc DNA
was performed at CERMEL, as published previously.22
Treatment and follow-up
Patients with conﬁrmed UGS by at least one urine sample or
by FASUS expert interpretation were treated with a single dose
of praziquantel (40 mg/kg). If non-UGS-related pathology was
found in the FASUS examination, the participant was referred for
further management.
Follow-upvisits tookplace1(M1)and3(M3)moafter treatment.
Procedures performed during follow-up comprised a clinical
investigation, urine analysis by dipstick and microscopy. Patients
with FASUS ﬁndings suggestive of UGS at enrolment underwent
a follow-up scan, which was reviewed and documented similar
to enrolment, but using a slightly shorter report form. In cases of
persistent signs of urinary tract pathology at M3, retreatment
with praziquantel was provided. If advanced UGS-related
pathology was not responsive to treatment, the participant was
referred to urologic care Gabon’s capital Libreville for further
management.
FASUS
FASUS scans were performed and evaluated by one of the two
operators (Table 1). FASUS videoclips and images were stored
and remotely reviewed and independently interpreted by two
ultrasound experts (SB and EJ). This reference test was chosen
because cystoscopic evaluation of the bladder as a gold standard
would not have beenmedically or ethically justiﬁed, and a locally
performed expert reference scan was not feasible in the absence
of experts.
A portable low-cost ultrasound device (MINDRAY Digital Ultra-
sonic Diagnostic Imaging System model DP-10, Mindray Medical
4
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Table 2. Ultrasound image quality sufﬁcient for expert interpretation
Bladder scana Right kidney scan Left kidney scan
Ultrasound operatorb Total scans Bladder wall Distal
ureters
Renal pelvis Proximal
ureter
Renal pelvis Proximal
ureter
Operator one, n (%) 118c 107
(91)
100
(88)
117
(99)
115
(97)
115
(97)
114
(97)
Operator two, n (%) 106 95
(90)
93
(88)
106
(100)
103
(97)
104
(98)
104
(98)
acombination of transverse and longitudinal scan, when available.
bbaseline scans performed by operator one, follow-up scans performed by operator two.
cfor distal ureter views at baseline: n=114.
International Limited, Shenzhen, China) with a curved array
transducer (MINDRAY model 35C50EB) was used for training
as well as for study procedures. Participants underwent FASUS
examination either in their homes or at CERMEL following stan-
dardized scanning conditions (the same ultrasound equipment,
patients in a supine position, a darkened room, the operator
seated on the patient’s right side). FASUS at enrolment was
performed by operator one (JR) and all follow-up scans by
operator two (AV). Sufﬁcient bladder ﬁlling, deﬁned as complete
distention of the bladder, was attempted as a precondition
to the examination. Anonymized patient data and ultrasound
ﬁndings were documented on a clinical record form. Images
were stored as digital video clips (Audio Video Interleave (AVI)
format) on the ultrasound device; if pathology was suspected,
additional still images (JPEG format) were stored. Anonymized
data were transferred to an external hard drive, compressed
using the open source video transcoder HandBrake (https://ha
ndbrake.fr) and bundled into zip ﬁles using the program 7zip
(http://www.7-zip.org) in order to reduce the ﬁle size for upload.
Zip ﬁles were uploaded to the secure teleradiology platform Col-
legium Telemedicus (https://collegiumtelemedicus.org) together
with basic clinical data (age, gender, current complaints and
history).
All images were independently reviewed by the two experts,
who were blinded to the operators’ ﬁndings and laboratory data.
Review criteria included the diagnostic quality of the scan (overall
image quality, depth, gain, focus, anatomical orientation and
sufﬁcient bladder ﬁlling) as well as the presence of pathology, as
presented in Table 1. The experts documented their ﬁndings in an
anonymized digital Portable Document Format (PDF) report form.
Any discrepant readings between the reviewers were resolved by
consensus. For pragmatic purposes, discrepancies in the severity
grading of bladder wall pathology were not resolved and only the
expert ﬁndings of the radiologist EJ are presented here.
Analysis
Data were entered into OpenClinica version 3.0.4 (OpenClinica,
Boston, MA, USA). Data analysis was performed using Microsoft
Excel (Microsoft, Redmond, WA, USA).
Results
Participants
Between December 2015 and June 2016, 119 participants
were enrolled. One patient withdrew consent after enrolment.
The cohort comprised 27 (23%) preschool-age children (PSAC,
aged <6 y), 56 (47%) school-age children (SAC, aged 6–15 y)
and 35 (30%) adults (aged >15 y); 56/118 (47%) were females.
Microscopic hematuria on dipstick was present in 103/118 (87%)
patients. Urine microscopy was positive for S. haematobium in
105/118 (89%) patients; 69/118 (58%) patients were heavily
infected. S. haematobium PCRwas negative in all 13 patients with
negative microscopy. M1 follow-up was performed for a total of
70/118 (59%) patients, M3 follow-upwas performed for a total of
82/118 (69%) patients. Age and gender distribution of the follow-
up cohort was comparable with the entire study population.
Image quality
Of a total of 224 FASUS scans, 178 (79%) were performed at the
patients’ residences and 46 (21%) at CERMEL. The proportion of
views considered of sufﬁcient quality for diagnostic interpretation
is presented in Table 2. The quality of bladder viewswas sufﬁcient
in 22/27 (81%) PSAC, 54/56 (96%) SAC and 31/35 (89%) adults.
Image depth, gain and focuswere rated as good in 99%, 98%and
98% of all scans, respectively. The bladder was entirely displayed
in 95% of the recorded sweeps. Bladder ﬁlling was judged sufﬁ-
cient in 86%; in 7 out of 11 bladder scans with insufﬁcient quality,
the bladder was underﬁlled. Anatomical orientation of the kidney
scans was good in 92% with the recorded sweep displaying the
renal pelvis in 99%.
Ultrasound ﬁndings
Pathological features compatiblewith UGS among baseline scans
of sufﬁcient quality were documented in 51/118 (43%) of cases
by the operator and in 46/107 (43%) by the experts, respectively.
Frequencies of UGS-related pathologies at baseline by operator
and experts are presented in Figure 3. Detection rates of bladder
wall pathology, kidney pelvis and proximal ureter dilation were
similar between operator and experts. Distal ureter dilation or
5
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Figure 3. Pathology detected by Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS) at baseline by operator and expert; NA,
not available.
thickening was detected three times as often by the experts
than by the operator. Frequencies of UGS-related pathologies at
baseline as assessed by the experts in relation to parasitology
results are presented in Figure 4. With increasing intensity of
infection, bladder and upper urinary tract pathology was more
frequently detected.
Taking expert ﬁndings as the gold standard, the operators
missed features compatible with UGS in 21/202 (10%) cases and
overdiagnosed features compatible with UGS in 9/202 (4%) cases
when adding baseline and follow up scans. Sensitivities and
speciﬁcities of the FASUS operator against the reference standard
of a remote expert review are presented in Table 3.
The highest agreement between operators and experts was
observed in the detection of renal pelvis dilation, followed by
bladder wall thickening of ≥5 mm and proximal ureter dila-
tion. For distal ureter pathology, agreement was lowest for both
operators; inter-rater agreement expressed as Cohen’s Kappa is
presented in Table 3.
The development of image quality, diagnostic accuracy and
inter-rater agreement with increasing number of scans is pre-
sented in Figure 5 for each operator.
Among 85 cases assessed by both transverse and longitudinal
bladder scan, pathology compatible with UGS was detected in 35
(41%) cases by transverse scan alone comparedwith 38 (45%) by
a combination of both scans.
In ﬁve cases, renal pelvis and/or ureter dilation was present
without bladder wall thickening of≥5mm. One of these patients
was pregnant, and in three others bladder wall irregularities
were present. All ﬁve were positive for S. haematobium in urine
microscopy.
Pathology not related to UGS was detected in 1/118 (1%)
patients by the operators and in 9/118 (8%) patients by the
experts and comprised free ﬂuid in the pelvis (n=3), non-
speciﬁc kidney lesions (n=2), pregnancy-related hydronephrosis,
a urachal remnant, non-speciﬁc uterine lesions and non-speciﬁc
strands in the bladder.
During follow-up, pathology compatible with UGSwas present
in 15/46 (33%) cases at M1 and in 16/49 (33%) cases at M3
among scans of sufﬁcient quality. Hydronephrosis was present
in 3/51 (6%) and 3/54 (6%) cases at M1 and M3, respectively. As
criteria for follow-up were not consistent, these rates cannot be
used to measure treatment success.
Discussion
This pilot study was the ﬁrst to evaluate a POCUS protocol for the
detection of UGS-related pathology of the urinary tract in symp-
tomatic patients living in a highly endemic area. It showed that
POCUS operators with limited training can detect such pathology
with high accuracy, compared with expert ultrasound operators.
Inter-rater agreement between operator and expert was good
for the detection of bladder wall pathology and very good for
hydronephrosis. Image quality was sufﬁcient in more than 88%
of all scans.
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Figure 4. Pathology detected by Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS) at baseline (expert review) in relation to
parasitology; aurine microscopy and PCR; brenal pelvis dilation >1 cm, proximal ureter dilation or distal ureter dilation/thickening.
Table 3. Accuracy of newly trained operators, compared to expert ultrasound opinion
Accuracya Bladder wall thickening
≥ 5mm
Distal ureter dilation/
thickening
Proximal ureter
dilation
Renal pelvis
dilation > 1cmb
Operatorc 1 2 1 2 1 2 1 2
Total scansd 107 95 87 93 111 102 110 104
Sensitivity (%) 83 68 17 23 57 50 100 83
Speciﬁcity (%) 90 95 97 99 100 95 98 100
Observed inter-
rater agreement
0.87 0.83 0.86 0.88 0.97 0.94 0.98 0.99
Cohen’s Kappa 0.73
“good”
0.64
“good”
0.19
“poor”
0.31
“fair”
0.71
“good”
0.23
“fair”
0.85
“very good”
0.90
“very good”
aUltrasound operator ﬁndings compared to expert consensus after remote review of recorded clips.
bIf conﬁrmed after bladder voiding, or if severe.
cBaseline scans performed by operator one, follow up scans performed by operator two.
dNumber of scans of sufﬁcient image quality for interpretation by operator and expert consensus.
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Figure 5.Operator improvement in bladder wall assessment; aimage quality of bladder scans sufﬁcient for expert interpretation; bultrasound operator
ﬁndings compared with expert consensus after remote review of recorded clips.
Protocol design
In our protocol, pathology compatible with UGS was deﬁned as
bladder wall thickening ≥5 mm. This cut-off was chosen based
on existing Niamey criteria. However, in many cases bladder
wall irregularities of <5 mm were detected, indicating that less
advanced pathology, compatible with UGS, can also be detected
with current equipment and short, focused training. This ﬁnd-
ing may be of value, as an earlier detection of morbidity may
inﬂuence management decisions. Differentiation of bladder wall
irregularities from a normal bladder wall remains challenging, as
illustrated by Figure 2 and reported in other studies.10 Therefore,
a threshold of 5mmappears sensible to limit false positive cases.
To keep the protocol as pragmatic as possible for use in the clinical
setting, a classiﬁcation of pathology severity, combining bladder
and upper urinary tract pathology, as applied in other studies,5,23
was not used. However, as upper urinary tract pathology with
concurrent bladder wall irregularities of less than 5 mm is also
likely to be due to UGS (although classiﬁed as ‘not compatible
with UGS’ in our study), this approach needs to be reconsidered
in larger validation studies.
As expected, the operators detected fewer abnormalities not
related to UGS. The aim of POCUS is to answer a very speciﬁc
clinical question, in this case: ‘Are there ﬁndings compatible with
UGS?’ and not to provide a comprehensive ultrasound examina-
tion or to exclude the presence of other pathology.
While the Niamey protocol12 comprises only a transverse view
of the bladder, we added a longitudinal bladder view assuming a
higher sensitivity for the detection of pathology, especially at the
bladder dome. With three additional cases of bladder pathology
detected by the additional longitudinal view, we recommend
including this view in further evaluations of this protocol.
Training
During training and data collection, the team was repeatedly
approached by local healthcare staff willing to learn the method,
demonstrating the general interest in the achievement of ultra-
sound skills among local clinicians.
Remote training support and image assessment proved effec-
tive in attaining good image quality, but as it comprised only
scans in healthy volunteers, identiﬁcation of pathology could
be learnt in theory only. An electronic learning module with
quiz-like elements could resolve this deﬁcit. Although remote
feedback was given for study patient scans as well, it was stag-
gered and therefore time-delayed. The optimal number of train-
ing scans for FASUS needs to be determined. A broad spectrum
of training requirements for point-of-care ultrasound protocols,
ranging from a few hours to several days, has been proposed
depending on sonographic complexity and previous ultrasound
knowledge.24–26
Image quality
Overall image quality was very good with more than 90% of
bladderwalls andmore than 97%of kidneys and proximal ureters
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being assessable by the experts. The display of distal ureters was
slightly more challenging. The high expert ratings on gain, depth
and focus settings show the effectiveness of the chosen remote
training model.
Image quality was best among SAC due to excellent displays
of deep anatomical structures related to smaller size. Inferior
image quality among PSAC and some adults can be explained
by limited compliance and additional body fat, respectively.
Interestingly, only two kidney scans and no bladder scans
were rated as ‘unable to assess’ by operator one, and only two
bladders and one kidney scan by operator two, showing that the
operators attempted to make assessments, despite limitations
in image quality. This is a potential source of error and future
training should emphasize this risk.
As reported in other studies,10 sufﬁcient bladder ﬁlling is cru-
cial for the quality of bladder scans. In the absence of a deﬁnition
or measurement for sufﬁcient bladder ﬁlling, in our study insuf-
ﬁcient bladder ﬁlling was judged by eyeballing bladder content
and wall. For future application of FASUS, a clear deﬁnition of suf-
ﬁcient or insufﬁcient bladder ﬁlling would be valuable; however,
includingmeasurements of bladder volumes for age-related nor-
mal rangeswould considerably increase complexity. Learning the
critical point of insufﬁcient bladder ﬁlling needs to be part of
FASUS training.
Accuracy of pilot operators compared with
experts
Overall, the accuracy of FASUS, performed by our pilot operators,
was good for the detection of bladderwall thickening≥5mmand
very good for the detection of hydronephrosis. Accuracy for the
detection of ureter pathology was lower, with 8/10 and 5/6 cases
of distal ureter pathology missed by the two operators, respec-
tively. As all cases of distal ureter pathology occurred together
with bladder wall pathology, the additional diagnostic value of
distal ureter assessment needs to be questioned. Considering its
difﬁculty, it should be omitted from the protocol.
While image quality and sensitivity improved for both opera-
tors over the course of the study, there was a slight decline in
speciﬁcity. Although conclusions need to be treated with caution
due to the small sample size, this might point to a shift from
underestimation to overestimation of pathology with an increas-
ing number of scans.
In another study on the learning curve of the more com-
plicated Niamey protocol for prevalence surveys by Bonnard
et al., sensitivity and speciﬁcity of the learner in comparison
with the teacher had reached 100% for both after 5 d and 91
examinations.27 However, the teacher directly supervised the
learner, in contrast to the staggered remote feedback over the
period of around 3 mo per operator in our study. Furthermore,
the authors were unclear whether the learning clinician had
previous ultrasound experience. Two other studies on remotely
reviewed POCUS in tropical medicine describing the detection of
extrapulmonary TB provided a sensitivity and speciﬁcity of the
operator compared with the expert that was comparable to our
study.28,29 However, unlike our approach, the examinations were
transmitted and assessed remotely in real time and not via saved
video clips, thus limiting comparison.
As urinary tract pathology increased with increasing intensity
of infection in this as well as in other studies,30 an algorithm
which combines parasitological with ultrasonographic ﬁndings,
especially in patients with a heavy intensity of infection, could
maximize diagnostic accuracy.
Overall, the learning of this POCUS technique via remote
review and feedback appears to be feasible and leads to good
accuracy that can be maintained over longer periods.
Of note, as the intention of this study was not to identify infec-
tion rates, the reported rate of UGS-related pathology among the
study population does not reﬂect that in the general population
in Gabon.
Management of pathological ﬁndings
As sonographic detection of UGS-related pathology has mostly
been used in the evaluation of large-scale control programs, no
algorithms for individual patient management based on ultra-
sound are available. FASUS could help in the identiﬁcation of
at-risk patients in need of regular follow-up and retreatment
in areas where regular preventive treatment is not indicated or
insufﬁciently implemented. Patients with advanced pathology
such as therapy-resistant hydronephrosis or suspicious bladder
lesions could be referred for further diagnostics and manage-
ment, where available.
Limitations
As a pilot study, the protocol underwent changes during the
course of the study, thus parts of the data are incomplete.
Our reference test of a remote expert review is inferior to
a locally performed expert reference scan, but was the best
and only feasible option in the absence of local expertise. With
only quality-reduced clips and still images as a basis for the
interpretation, pathologymight have beenmissed by the experts
or normal ﬁndings and artifacts mistaken for pathology. How-
ever, this telemedicine-based training and image review design
provides a feasible model for POCUS training in resource-limited
settings where no alternative options exist.
Conclusions
FASUS is a promising bedside diagnostic tool for detection of
UGS-related morbidity in symptomatic patients living in highly
endemic areas. Simple protocols and short training appear ade-
quate and feasible, despite the common limitations present in
a low-resource setting, such as novice clinician trainees, low-
budget ultrasound devices and examinations performed in the
ﬁeld. If further validation studies conﬁrm the utility of FASUS,
internationally agreeable standards for training and competency
should be set. Based on data from larger cohorts, appropri-
ate diagnostic and therapeutic algorithms for its use in routine
patient care should be established.
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